Hoth Therapeutics (NASDAQ:HOTH) just reported results for the first quarter of 2024.
- Hoth Therapeutics reported earnings per share of -46 cents. This was below the analyst estimate for EPS of -43 cents.
- The company did not report any revenue for the quarter.